• Editorial building evidence to manage newborn jaundice worldwide

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/22183759Editorial: building evidence to manage newborn jaundice worldwide网页Editorial: building evidence to manage newborn jaundice worldwide. Editorial: building evidence to manage newborn jaundice worldwide. Indian J Pediatr. 2012 Feb;79 (2):253-5. doi: 10.1007/s12098-011-0631-6. Epub 2011 Dec 20.  

发布时间：2024-07-13

• Should Central Banks Respond to Movements in Asset Prices

发布时间：2024-07-13

• Clinical Response and Remission in Patients With Severe

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/37925144Clinical Response and Remission in Patients With Severe …网页Anti-Asthmatic Agents. Biological Products. Clinical response was achieved in most adult patients initiating biologic therapy, and clinical remission was observed in 19% of the patients following 12 months of treatment. Further studies are required to assess the long-term outcome of achieving clinical remission with biologic therapy.

发布时间：2024-07-13

• IP 1011253 页面 用户名 密码 IP地址 简体中文

发布时间：2024-07-13

• Precision teaching's unique legacy from B F Skinner

发布时间：2024-07-13

• 如何排查并解决缺少默认路由配置导致无法访问网络

发布时间：2024-07-13

• 213925314212003

data-id="" iid="">2.139.253.142http://2.139.253.142:120032.139.253.142:12003网页由于此网站的设置，我们无法提供该页面的具体描述。

发布时间：2024-07-13

• IP 1921682253 Trang đăng nhập Tên người dùng Mật khẩu

发布时间：2024-07-13

• FTBMT a Novel and Selective GPR52 Agonist Demonstrates

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/28851764FTBMT, a Novel and Selective GPR52 Agonist, Demonstrates ... - PubMed网页In the current study, we investigated the in vitro and in vivo pharmacologic activities of a novel GPR52 agonist, 4-(3-(3-fluoro-5-(trifluoromethyl)benzyl)-5-methyl-1H-1,2,4-triazol-1-yl)-2-methylbenzamide (FTBMT). FTBMT functioned as a selective GPR52 agonist in vitro and in vivo, as demonstrated by the activation of Camp signaling in striatal ...

发布时间：2024-07-13